The Patent Finder

Use of Bethaneciol for Treatment of Xerostomia

Acacia Pharma Limited

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/GB2010/051887, filed Nov 11, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,149,454Use of Bethaneciol for Treatment of Xerostomia
In force
 · High confidence
UsedRemaining
Acacia Pharma LimitedIn forceHigh confidence
US 10,137,084Use of Bethanechol for Treatment of Xerostomia
In force
 · High confidence
Acacia Pharma LimitedIn forceHigh confidence
Application 14/842,297Use of Bethanechol for Treatment of Xerostomia
Abandoned
Abandoned Apr 17, 2016
Acacia Pharma LimitedAbandonedAbandoned Apr 17, 2016
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Acacia Pharma Limited.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited